


The 340B Dilemma: The Power of Vague Law
July 21, 2025 By Angela Lamari, Capstone Healthcare analyst At only eight and a half pages of statute, the federal 340B drug pricing program is a clear example of how industry speaks when the law is silent. The program itself is fairly simple—in 1992, the government...
Policymaker Interest in Healthcare AI Heats Up
April 30, 2025 By Grace Totman, Co-Head of Capstone’s Healthcare Practice Capstone believes that scrutiny of artificial intelligence (AI) in healthcare will increase state-level efforts to restrict its use, notably in utilization management (UM). This will...
The Growing Healthcare Provider Shortage Problem
February 10, 2025 By Wylie Butler, Capstone Healthcare Analyst Every great healthcare analyst starts their origin journey as pre-med student. Based on the latest healthcare workforce projections, it might have been better if a few of us had stuck to the path. More and...
US-China Tensions: Growing Restrictions and Expanding Global Risks
January 3, 2025 By Elena McGovern, Co-Head of Capstone’s National Security Team Download the Report Capstone expects the US-China competition to intensify as the incoming Trump administration has made reining in China a cornerstone of its foreign policy. We...